The Selection and Use of Essential Medicines - WHO Technical Report Series, No. 920
(2003; 137 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documento1. Introduction
Ver el documento2. Open session
Cerrar esta carpeta3. Update on current activities
Ver el documento3.1 Dissemination of the previous report of the Expert Committee (including the 12th Model List)
Ver el documento3.2 The twenty-fifth anniversary of the WHO Model List of Essential Medicines
Ver el documento3.3 The WHO model formulary
Ver el documento3.4 Review of the New Emergency Health Kit
Ver el documento3.5 Review of essential medicines for reproductive health
Ver el documento3.6 Report of an ad hoc Advisory Committee on priority vaccines
Ver el documento3.7 The WHO Essential Medicines Library
Cerrar esta carpeta3.8 Promoting rational use of essential medicines
Ver el documento3.8.1 Update on activities to contain antimicrobial resistance
Ver el documento3.8.2 Guidelines for drugs and therapeutic committees
Ver el documento3.8.3 WHO database on rational drug use studies
Abrir esta carpeta y ver su contenido4. Changes made in revising the Model List
Abrir esta carpeta y ver su contenido5. Reviews of sections of the Model List
Ver el documento6. Priorities for future reviews
Abrir esta carpeta y ver su contenido7. Recommendations
Ver el documentoReferences
Ver el documentoAnnex 1 The 13th WHO Model List of Essential Medicines
Ver el documentoAnnex 2 The Anatomical Therapeutic Chemical (ATC) classification system1
Ver el documentoAlphabetical list of essential medicines (with ATC classification code numbers)
Ver el documentoSelected WHO Publications of Related Interest
 

3.8.2 Guidelines for drugs and therapeutic committees

Drugs and therapeutics committees (DTCs) - sometimes called pharmacy and therapeutics committees - are designated to ensure the safe and effective use of medicines in the facility or area under their jurisdiction. Such committees are well established in most industrialized countries as a successful way of promoting a more rational, cost-effective use of medicines in hospitals. WHO promotes the establishment of DTCs through its international training courses (which are run in collaboration with MSH), the preparation of a manual on DTCs and various other research projects.

The main responsibilities of a DTC are:

- developing, adapting or adopting clinical guidelines for the health institution or health facilities under its jurisdiction;

- selecting cost-effective and safe medicines (hospital/health facilities' drug formulary);

- implementing and evaluating strategies to improve medicine use (including drug use evaluations, and liaison with antibiotic and infection control committees);

- providing ongoing staff education (training and printed materials);

- controlling access to staff by the pharmaceutical industry and its promotional activities;

- monitoring and taking action to prevent adverse drug reactions and medication errors;

- providing advice about other drug management issues, such as quality and expenditure.


Governments should encourage all hospitals to set up a DTC (e.g. by making it an accreditation requirement to various professional societies) with a membership that represents all the major specialities and the administration. DTC members should be independent and declare any conflict of interest. A senior doctor would usually be the chairperson and the chief pharmacist, the secretary. Factors critical to success include: clear objectives, a firm mandate, support from the senior hospital management, transparency, wide representation, technical competence, a multidisciplinary approach and sufficient resources to implement the DTC's decisions.

The WHO manual on establishing and running a DTC will be issued in 2003 (10); international 2-week training courses are ongoing in Asia and Africa.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 19 enero 2012